10 20 30 40 50 60 70 80 2HUF - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 26-JUL-06 2HUF
TITLE CRYSTAL STRUCTURE OF AEDES AEGYPTI ALANINE GLYOXYLATE TITLE 2 AMINOTRANSFERASE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALANINE GLYOXYLATE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.6.1.44; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AEDES AEGYPTI; SOURCE 3 ORGANISM_COMMON: YELLOW FEVER MOSQUITO; SOURCE 4 ORGANISM_TAXID: 7159; SOURCE 5 STRAIN: LIVERPOOL; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PBLUEBAC4.5
KEYWDS ALPHA AND BETA PROTEIN, PLP-DEPENDENT TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR Q.HAN,H.ROBINSON,Y.G.GAO,N.VOGELAAR,S.R.WILSON,M.RIZZI,J.LI
REVDAT 4 24-FEB-09 2HUF 1 VERSN REVDAT 3 12-DEC-06 2HUF 1 JRNL REVDAT 2 21-NOV-06 2HUF 1 JRNL REVDAT 1 26-SEP-06 2HUF 0
JRNL AUTH Q.HAN,H.ROBINSON,Y.G.GAO,N.VOGELAAR,S.R.WILSON, JRNL AUTH 2 M.RIZZI,J.LI JRNL TITL CRYSTAL STRUCTURES OF AEDES AEGYPTI ALANINE JRNL TITL 2 GLYOXYLATE AMINOTRANSFERASE. JRNL REF J.BIOL.CHEM. V. 281 37175 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16990263 JRNL DOI 10.1074/JBC.M607032200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 84776 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4233 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5884 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.2040 REMARK 3 BIN FREE R VALUE SET COUNT : 331 REMARK 3 BIN FREE R VALUE : 0.2490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5956 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 520 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.106 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.103 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.903 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6096 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8270 ; 1.635 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 768 ; 5.898 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 250 ;34.076 ;23.120 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1022 ;17.157 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 46 ;20.560 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 924 ; 0.180 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4580 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3203 ; 0.219 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4181 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 520 ; 0.111 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 16 ; 0.318 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.094 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3911 ; 0.987 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6136 ; 1.324 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2474 ; 2.311 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2134 ; 3.584 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS
REMARK 4 REMARK 4 2HUF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-06. REMARK 100 THE RCSB ID CODE IS RCSB038773.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SI(111) OR (220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 84787 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.000 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1H0C REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 8000, 0.13 M MAGNESIUM REMARK 280 ACETATE, 4% BUTANOL, 0.1 M CACODYLIC ACID, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 68.48200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.53810 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.15767 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 68.48200 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 39.53810 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 40.15767 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 68.48200 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 39.53810 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 40.15767 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 79.07620 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 80.31533 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 79.07620 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 80.31533 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 79.07620 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 80.31533 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 386 REMARK 465 VAL A 387 REMARK 465 GLN A 388 REMARK 465 VAL A 389 REMARK 465 LYS A 390 REMARK 465 GLY A 391 REMARK 465 LYS A 392 REMARK 465 MET A 393 REMARK 465 ASP B 386 REMARK 465 VAL B 387 REMARK 465 GLN B 388 REMARK 465 VAL B 389 REMARK 465 LYS B 390 REMARK 465 GLY B 391 REMARK 465 LYS B 392 REMARK 465 MET B 393
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 62 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG A 62 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 108 CD - NE - CZ ANGL. DEV. = 8.5 DEGREES REMARK 500 ARG A 108 NE - CZ - NH1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ARG A 108 NE - CZ - NH2 ANGL. DEV. = -7.1 DEGREES REMARK 500 ILE A 214 CB - CA - C ANGL. DEV. = -12.0 DEGREES REMARK 500 VAL B 10 CG1 - CB - CG2 ANGL. DEV. = 9.9 DEGREES REMARK 500 ARG B 62 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG B 62 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ILE B 97 CB - CA - C ANGL. DEV. = -15.1 DEGREES REMARK 500 ARG B 108 NE - CZ - NH1 ANGL. DEV. = 6.8 DEGREES REMARK 500 ARG B 108 NE - CZ - NH2 ANGL. DEV. = -7.2 DEGREES REMARK 500 ILE B 214 CB - CA - C ANGL. DEV. = -13.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 78 -179.98 -68.73 REMARK 500 PHE B 251 -158.08 -118.01 REMARK 500 GLN B 324 116.36 -39.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 252 ARG B 253 -136.97 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1BO B 601 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1BO A 602
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HUI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF AEDES AEGYPTI ALANINE GLYOXYLATE REMARK 900 AMINOTRANSFERASE REMARK 900 RELATED ID: 2HUU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF AEDES AEGYPTI ALANINE GLYOXYLATE REMARK 900 AMINOTRANSFERASE
DBREF 2HUF A 1 393 UNP Q3LSM4 Q3LSM4_AEDAE 1 393 DBREF 2HUF B 1 393 UNP Q3LSM4 Q3LSM4_AEDAE 1 393
SEQADV 2HUF LLP A 206 UNP Q3LSM4 LYS 206 MODIFIED RESIDUE SEQADV 2HUF LLP B 206 UNP Q3LSM4 LYS 206 MODIFIED RESIDUE
SEQRES 1 A 393 MET GLU TYR LYS VAL THR PRO PRO ALA VAL LEU ARG GLU SEQRES 2 A 393 PRO LEU VAL THR PRO ASN LYS LEU LEU MET GLY PRO GLY SEQRES 3 A 393 PRO SER ASN ALA PRO GLN ARG VAL LEU ASP ALA MET SER SEQRES 4 A 393 ARG PRO ILE LEU GLY HIS LEU HIS PRO GLU THR LEU LYS SEQRES 5 A 393 ILE MET ASP ASP ILE LYS GLU GLY VAL ARG TYR LEU PHE SEQRES 6 A 393 GLN THR ASN ASN ILE ALA THR PHE CYS LEU SER ALA SER SEQRES 7 A 393 GLY HIS GLY GLY MET GLU ALA THR LEU CYS ASN LEU LEU SEQRES 8 A 393 GLU ASP GLY ASP VAL ILE LEU ILE GLY HIS THR GLY HIS SEQRES 9 A 393 TRP GLY ASP ARG SER ALA ASP MET ALA THR ARG TYR GLY SEQRES 10 A 393 ALA ASP VAL ARG VAL VAL LYS SER LYS VAL GLY GLN SER SEQRES 11 A 393 LEU SER LEU ASP GLU ILE ARG ASP ALA LEU LEU ILE HIS SEQRES 12 A 393 LYS PRO SER VAL LEU PHE LEU THR GLN GLY ASP SER SER SEQRES 13 A 393 THR GLY VAL LEU GLN GLY LEU GLU GLY VAL GLY ALA LEU SEQRES 14 A 393 CYS HIS GLN HIS ASN CYS LEU LEU ILE VAL ASP THR VAL SEQRES 15 A 393 ALA SER LEU GLY GLY ALA PRO MET PHE MET ASP ARG TRP SEQRES 16 A 393 GLU ILE ASP ALA MET TYR THR GLY SER GLN LLP VAL LEU SEQRES 17 A 393 GLY ALA PRO PRO GLY ILE THR PRO VAL SER PHE SER HIS SEQRES 18 A 393 ARG ALA VAL GLU ARG TYR LYS ARG ARG ASN THR LYS VAL SEQRES 19 A 393 LYS VAL TYR TYR TRP ASP MET SER LEU VAL GLY ASP TYR SEQRES 20 A 393 TRP GLY CYS PHE GLY ARG PRO ARG ILE TYR HIS HIS THR SEQRES 21 A 393 ILE SER SER THR LEU LEU TYR GLY LEU ARG GLU ALA ILE SEQRES 22 A 393 ALA MET ALA CYS GLU GLU GLY LEU PRO ALA LEU ILE ALA SEQRES 23 A 393 ARG HIS GLU ASP CYS ALA LYS ARG LEU TYR ARG GLY LEU SEQRES 24 A 393 GLN ASP ALA GLY PHE GLU LEU TYR ALA ASP PRO LYS ASP SEQRES 25 A 393 ARG LEU SER THR VAL THR THR ILE LYS VAL PRO GLN GLY SEQRES 26 A 393 VAL ASP TRP LEU LYS ALA ALA GLN TYR ALA MET LYS THR SEQRES 27 A 393 TYR LEU VAL GLU ILE SER GLY GLY LEU GLY PRO THR ALA SEQRES 28 A 393 GLY GLN VAL PHE ARG ILE GLY LEU MET GLY GLN ASN ALA SEQRES 29 A 393 THR THR GLU ARG VAL ASP ARG VAL LEU GLN VAL PHE GLN SEQRES 30 A 393 GLU ALA VAL ALA ALA VAL LYS PRO ASP VAL GLN VAL LYS SEQRES 31 A 393 GLY LYS MET SEQRES 1 B 393 MET GLU TYR LYS VAL THR PRO PRO ALA VAL LEU ARG GLU SEQRES 2 B 393 PRO LEU VAL THR PRO ASN LYS LEU LEU MET GLY PRO GLY SEQRES 3 B 393 PRO SER ASN ALA PRO GLN ARG VAL LEU ASP ALA MET SER SEQRES 4 B 393 ARG PRO ILE LEU GLY HIS LEU HIS PRO GLU THR LEU LYS SEQRES 5 B 393 ILE MET ASP ASP ILE LYS GLU GLY VAL ARG TYR LEU PHE SEQRES 6 B 393 GLN THR ASN ASN ILE ALA THR PHE CYS LEU SER ALA SER SEQRES 7 B 393 GLY HIS GLY GLY MET GLU ALA THR LEU CYS ASN LEU LEU SEQRES 8 B 393 GLU ASP GLY ASP VAL ILE LEU ILE GLY HIS THR GLY HIS SEQRES 9 B 393 TRP GLY ASP ARG SER ALA ASP MET ALA THR ARG TYR GLY SEQRES 10 B 393 ALA ASP VAL ARG VAL VAL LYS SER LYS VAL GLY GLN SER SEQRES 11 B 393 LEU SER LEU ASP GLU ILE ARG ASP ALA LEU LEU ILE HIS SEQRES 12 B 393 LYS PRO SER VAL LEU PHE LEU THR GLN GLY ASP SER SER SEQRES 13 B 393 THR GLY VAL LEU GLN GLY LEU GLU GLY VAL GLY ALA LEU SEQRES 14 B 393 CYS HIS GLN HIS ASN CYS LEU LEU ILE VAL ASP THR VAL SEQRES 15 B 393 ALA SER LEU GLY GLY ALA PRO MET PHE MET ASP ARG TRP SEQRES 16 B 393 GLU ILE ASP ALA MET TYR THR GLY SER GLN LLP VAL LEU SEQRES 17 B 393 GLY ALA PRO PRO GLY ILE THR PRO VAL SER PHE SER HIS SEQRES 18 B 393 ARG ALA VAL GLU ARG TYR LYS ARG ARG ASN THR LYS VAL SEQRES 19 B 393 LYS VAL TYR TYR TRP ASP MET SER LEU VAL GLY ASP TYR SEQRES 20 B 393 TRP GLY CYS PHE GLY ARG PRO ARG ILE TYR HIS HIS THR SEQRES 21 B 393 ILE SER SER THR LEU LEU TYR GLY LEU ARG GLU ALA ILE SEQRES 22 B 393 ALA MET ALA CYS GLU GLU GLY LEU PRO ALA LEU ILE ALA SEQRES 23 B 393 ARG HIS GLU ASP CYS ALA LYS ARG LEU TYR ARG GLY LEU SEQRES 24 B 393 GLN ASP ALA GLY PHE GLU LEU TYR ALA ASP PRO LYS ASP SEQRES 25 B 393 ARG LEU SER THR VAL THR THR ILE LYS VAL PRO GLN GLY SEQRES 26 B 393 VAL ASP TRP LEU LYS ALA ALA GLN TYR ALA MET LYS THR SEQRES 27 B 393 TYR LEU VAL GLU ILE SER GLY GLY LEU GLY PRO THR ALA SEQRES 28 B 393 GLY GLN VAL PHE ARG ILE GLY LEU MET GLY GLN ASN ALA SEQRES 29 B 393 THR THR GLU ARG VAL ASP ARG VAL LEU GLN VAL PHE GLN SEQRES 30 B 393 GLU ALA VAL ALA ALA VAL LYS PRO ASP VAL GLN VAL LYS SEQRES 31 B 393 GLY LYS MET
MODRES 2HUF LLP A 206 LYS MODRES 2HUF LLP B 206 LYS
HET LLP A 206 24 HET LLP B 206 24 HET 1BO B 601 5 HET 1BO A 602 5
HETNAM LLP 2-LYSINE(3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- HETNAM 2 LLP PYRIDIN-4-YLMETHANE) HETNAM 1BO 1-BUTANOL
HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE HETSYN 1BO BUTAN-1-OL
FORMUL 1 LLP 2(C14 H24 N3 O7 P) FORMUL 3 1BO 2(C4 H10 O) FORMUL 5 HOH *520(H2 O)
HELIX 1 1 PRO A 8 GLU A 13 5 6 HELIX 2 2 PRO A 31 MET A 38 1 8 HELIX 3 3 HIS A 47 GLN A 66 1 20 HELIX 4 4 SER A 78 LEU A 91 1 14 HELIX 5 5 GLY A 103 TYR A 116 1 14 HELIX 6 6 SER A 132 LYS A 144 1 13 HELIX 7 7 GLY A 165 HIS A 173 1 9 HELIX 8 8 SER A 220 ARG A 229 1 10 HELIX 9 9 VAL A 236 TRP A 239 5 4 HELIX 10 10 ASP A 240 TRP A 248 1 9 HELIX 11 11 SER A 262 GLY A 280 1 19 HELIX 12 12 GLY A 280 ALA A 302 1 23 HELIX 13 13 ASP A 309 ARG A 313 5 5 HELIX 14 14 ASP A 327 LEU A 340 1 14 HELIX 15 15 LEU A 347 ALA A 351 5 5 HELIX 16 16 MET A 360 ALA A 364 5 5 HELIX 17 17 THR A 365 LYS A 384 1 20 HELIX 18 18 PRO B 8 GLU B 13 5 6 HELIX 19 19 PRO B 31 MET B 38 1 8 HELIX 20 20 HIS B 47 GLN B 66 1 20 HELIX 21 21 SER B 78 LEU B 91 1 14 HELIX 22 22 GLY B 103 TYR B 116 1 14 HELIX 23 23 SER B 132 LYS B 144 1 13 HELIX 24 24 GLY B 165 GLN B 172 1 8 HELIX 25 25 SER B 220 ARG B 229 1 10 HELIX 26 26 VAL B 236 TRP B 239 5 4 HELIX 27 27 ASP B 240 TRP B 248 1 9 HELIX 28 28 SER B 262 GLY B 280 1 19 HELIX 29 29 GLY B 280 ALA B 302 1 23 HELIX 30 30 ASP B 309 ARG B 313 5 5 HELIX 31 31 ASP B 327 LEU B 340 1 14 HELIX 32 32 LEU B 347 ALA B 351 5 5 HELIX 33 33 MET B 360 ALA B 364 5 5 HELIX 34 34 THR B 365 LYS B 384 1 20
SHEET 1 A 2 LEU A 21 LEU A 22 0 SHEET 2 A 2 VAL A 341 GLU A 342 1 O GLU A 342 N LEU A 21 SHEET 1 B 7 ALA A 71 LEU A 75 0 SHEET 2 B 7 THR A 215 PHE A 219 -1 O VAL A 217 N PHE A 73 SHEET 3 B 7 ALA A 199 TYR A 201 -1 N MET A 200 O SER A 218 SHEET 4 B 7 LEU A 176 ASP A 180 1 N VAL A 179 O ALA A 199 SHEET 5 B 7 VAL A 147 THR A 151 1 N LEU A 148 O LEU A 176 SHEET 6 B 7 VAL A 96 HIS A 101 1 N LEU A 98 O VAL A 147 SHEET 7 B 7 ASP A 119 LYS A 124 1 O ARG A 121 N ILE A 99 SHEET 1 C 2 GLY A 153 ASP A 154 0 SHEET 2 C 2 VAL A 159 LEU A 160 -1 O VAL A 159 N ASP A 154 SHEET 1 D 2 VAL A 317 LYS A 321 0 SHEET 2 D 2 VAL A 354 GLY A 358 -1 O PHE A 355 N ILE A 320 SHEET 1 E 2 LEU B 21 LEU B 22 0 SHEET 2 E 2 VAL B 341 GLU B 342 1 O GLU B 342 N LEU B 21 SHEET 1 F 7 ALA B 71 LEU B 75 0 SHEET 2 F 7 THR B 215 PHE B 219 -1 O VAL B 217 N PHE B 73 SHEET 3 F 7 ALA B 199 TYR B 201 -1 N MET B 200 O SER B 218 SHEET 4 F 7 LEU B 176 ASP B 180 1 N VAL B 179 O ALA B 199 SHEET 5 F 7 VAL B 147 THR B 151 1 N LEU B 148 O ILE B 178 SHEET 6 F 7 VAL B 96 HIS B 101 1 N GLY B 100 O PHE B 149 SHEET 7 F 7 ASP B 119 LYS B 124 1 O ARG B 121 N ILE B 97 SHEET 1 G 2 GLY B 153 ASP B 154 0 SHEET 2 G 2 VAL B 159 LEU B 160 -1 O VAL B 159 N ASP B 154 SHEET 1 H 2 VAL B 317 LYS B 321 0 SHEET 2 H 2 VAL B 354 GLY B 358 -1 O ILE B 357 N THR B 318
LINK C GLN A 205 N LLP A 206 1555 1555 1.33 LINK C LLP A 206 N VAL A 207 1555 1555 1.33 LINK C GLN B 205 N LLP B 206 1555 1555 1.32 LINK C LLP B 206 N VAL B 207 1555 1555 1.33
CISPEP 1 GLY A 26 PRO A 27 0 3.99 CISPEP 2 GLY B 26 PRO B 27 0 3.00
SITE 1 AC1 6 HIS A 45 PRO B 25 SER B 155 LEU B 347 SITE 2 AC1 6 ARG B 356 HOH B 816 SITE 1 AC2 5 SER A 155 ARG A 356 HOH A 833 HIS B 45 SITE 2 AC2 5 TYR B 257
CRYST1 136.964 136.964 120.473 90.00 90.00 120.00 H 3 18
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007301 0.004215 0.000000 0.00000
SCALE2 0.000000 0.008431 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008301 0.00000